Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 535-544
Open Access | Times Cited: 278

Showing 51-75 of 278 citing articles:

Molecular mimicry and cancer vaccine development
Maria Tagliamonte, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Mode of action of Akkermansia muciniphila in the intestinal dialogue: role of extracellular proteins, metabolites and cell envelope components
Anneleen Segers, Willem M. de Vos
Microbiome Research Reports (2023) Vol. 2, Iss. 2, pp. 6-6
Open Access | Times Cited: 26
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 24
Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia
Emmanuel Montassier, Georgios D. Kitsios, Josiah E. Radder, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2793-2804
Closed Access | Times Cited: 23
Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Marius Bredon, Camille Danne, Hang‐Phuong Pham, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Unlocking the power of postbiotics: A revolutionary approach to nutrition for humans and animals
Xinjie Zhao, Shuai Liu, Sumin Li, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 725-744
Open Access | Times Cited: 13
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 13
Western diets and chronic diseases
Timon E. Adolph, Herbert Tilg
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2133-2147
Closed Access | Times Cited: 13
Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy
Siyuan Cheng, Zihan Han, Die Dai, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101355-101355
Open Access | Times Cited: 12
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Interactions between diet and gut microbiota in cancer
Geicho Nakatsu, Natalia Andreeva, M. Macdonald, et al.
Nature Microbiology (2024) Vol. 9, Iss. 7, pp. 1644-1654
Closed Access | Times Cited: 10
Integrating the gut microbiome and pharmacology
Andrew A Verdegaal, Andrew L. Goodman
Science Translational Medicine (2024) Vol. 16, Iss. 732
Closed Access | Times Cited: 9
Novel strategies for modulating the gut microbiome for cancer therapy
Young Seok Cho, Kai Han, Jin Xu, et al.
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115332-115332
Closed Access | Times Cited: 9
Type 1 diabetes: A new vision of the disease based on endotypes
Craig Sinclair Weston, Bernhard O. Boehm, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 8
Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts
Paolo Manghi, Amrisha Bhosle, Kai Wang, et al.
Nature Microbiology (2024)
Open Access | Times Cited: 8
International consensus statement on microbiome testing in clinical practice
Serena Porcari, Benjamin H. Mullish, Francesco Asnicar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 2, pp. 154-167
Closed Access | Times Cited: 8
Gut microbiome and immune checkpoint inhibitor toxicity
Rik J. Verheijden, Mick J M van Eijs, Fernanda L. Paganelli, et al.
European Journal of Cancer (2025) Vol. 216, pp. 115221-115221
Closed Access | Times Cited: 1
Polysaccharides from Sea Cucumber (Stichopus japonicus) Synergize with Anti-PD1 Immunotherapy to Reduce MC-38 Tumor Burden in Mice Through Shaping the Gut Microbiome
Jiahui Li, Jinhui Jia, Yue Teng, et al.
Foods (2025) Vol. 14, Iss. 3, pp. 387-387
Open Access | Times Cited: 1
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Puspendu Sardar, Benjamin S. Beresford-Jones, Wangmingyu Xia, et al.
Nature Microbiology (2025) Vol. 10, Iss. 3, pp. 795-807
Open Access | Times Cited: 1
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Shijiao Hou, Jiachen Yu, Yongshuang Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine
Nicolas D. Huyghe, Elena Benidovskaya, Philippe Stevens, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2241-2241
Open Access | Times Cited: 37
Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
Sebastian Wurster, Stephanie S. Watowich, Dimitrios P. Kontoyiannis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis
Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5405-5405
Open Access | Times Cited: 29
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update
Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5643-5643
Open Access | Times Cited: 20
Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction
Ruixia Song, Fengsen Liu, Yu Ping, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 19

Scroll to top